SCHEMBL7218337

SCHEMBL7218337

CC(C)(C)NCCCn1ccc(NC(=O)c2c[nH]c3c2-c2ncccc2CCC3)n1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCK P35557 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
KDM4E B2RXH2 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2D6 P10635 1/20 0.31
ALOX15 P16050 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
LMNA P02545 1/20 0.31
PDE4B Q07343 1/20 0.31
PDE4D Q08499 1/20 0.31
CHRM2 P08172 1/20 0.30
CHRM4 P08173 1/20 0.30
CHRM1 P11229 1/20 0.30
CHRM3 P20309 1/20 0.30
RET P07949 2/20 0.30
KDR P35968 2/20 0.30
GRM5 P41594 1/20 0.30
EGFR P00533 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
CYP2C9 P11712 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7222707 0.95 GCK (0.34) GCKNPSR1KDM4ELMNAPDE4B
SCHEMBL7223026 0.91 GCK (0.33) GCKNPSR1LMNAPDE4BPDE4D
SCHEMBL7221707 0.91 GCK (0.32) GCKNPSR1
SCHEMBL7222958 0.89 NPSR1 (0.34) GCKNPSR1KDM4ELMNAPDE4B
SCHEMBL7222537 0.89 GCK (0.32) GCKNPSR1
SCHEMBL7223214 0.88 NPSR1 (0.34) GCKNPSR1KDM4ELMNAPDE4B
SCHEMBL7217024 0.88 PDE4B (0.31) GCKNPSR1PDE4BPDE4D
SCHEMBL7223193 0.88 PIM1 (0.32) GCKNPSR1CYP2D6PDE4BPDE4D
SCHEMBL7216130 0.88 GCK (0.36) GCKNPSR1KDM4ECYP1A2CYP2D6
SCHEMBL7223491 0.87 GCK (0.32) GCKNPSR1KDM4EPDE4BPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6653471-B2 Tricyclic heteroaromatic compounds containing pyrrole ring; central nervous system disorder treatment; side effect reduction NEUROGEN CORPORATION 2003-11-25 US disclosed